A thermosensitive morphine-containing hydrogel for the treatment of large-scale skin wounds

International Journal of Pharmaceutics

Volumn 444, Issue 1-2, 2013, Pages 96-102

  Heilmann, Sarah ^a   Küchler, Sarah ^b   Wischke, Christian ^c,d   Lendlein, Andreas ^c,d   Stein, Christoph ^a,d   Schäfer Korting, Monika ^a,d  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c INSTITUTE OF MATERIALS RESEARCH   (Germany)

^d Helmholtz Virtual Institute for Multifunctional Biomaterials for Medicine   (Germany)

Author keywords

Morphine; Percutaneous absorption; Reconstructed human skin; Sustained release; Thermosensitive hydrogel

Indexed keywords

HYDROXYETHYLCELLULOSE; MORPHINE; POLOXAMER;

ARTICLE; CONCENTRATION (PARAMETERS); DRUG ABSORPTION; DRUG RELEASE; HEAT SENSITIVITY; HUMAN; HYDROGEL; PRIORITY JOURNAL; SKIN ABSORPTION; SKIN INJURY; VISCOSITY;

ANALGESICS, OPIOID; HOT TEMPERATURE; HUMANS; HYDROGEL; MORPHINE; POLOXAMER; SKIN; SKIN ABSORPTION; SURFACE-ACTIVE AGENTS; WOUND HEALING;

EID: 84873701844     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.01.027     Document Type: Article

References (37)

1. K. Ackermann, S.L. Borgia, H.C. Korting, K.R. Mewes, and M. Schäfer-Korting The phenion full-thickness skin model for percutaneous absorption testing Skin Pharmacol. Physiol. 23 2010 105 112
2. BASF 2010. Technical information. http://www.pharma-ingredients.basf.com/ Statements/Technical%20Informations/EN/Pharma%20Solutions/03-100102e- Lutrol%20L%20and%20Lutrol%20F-Grades.pdf.
3. M. Bigliardi-Qi, L.T. Sumanovski, S. Buchner, T. Rufli, and P.L. Bigliardi Mu-opiate receptor and beta-endorphin expression in nerve endings and keratinocytes in human skin Dermatology 209 2004 183 189
4. P.L. Bigliardi, M. Bigliardi-Qi, S. Buechner, and T. Rufli Expression of mu-opiate receptor in human epidermis and keratinocytes J. Invest. Derm. 111 1998 297 301
5. P.L. Bigliardi, D.J. Tobin, C. Gaveriaux-Ruff, and M. Bigliardi-Qi Opioids and the skin - where do we stand? Exp. Derm. 18 2009 424 430
6. J.S. Boateng, K.H. Matthews, H.N. Stevens, and G.M. Eccleston Wound healing dressings and drug delivery systems: a review J. Pharm. Sci. 97 2008 2892 2923
7. N. Charbaji, M. Schäfer-Korting, and S. Küchler Morphine stimulates cell migration of oral epithelial cells by delta-opioid receptor activation PLoS ONE 7 2012 e42616
8. K. Derakhshandeh, M. Fashi, and S. Seifoleslami Thermosensitive Pluronic hydrogel: prolonged injectable formulation for drug abuse Drug Des. Devel. Ther. 4 2010 255 262
9. G. Dumortier, J.L. Grossiord, F. Agnely, and J.C. Chaumeil A review of poloxamer 407 pharmaceutical and pharmacological characteristics Pharm. Res. 23 2006 2709 2728
10. J.J. Escobar-Chavez, M. Lopez-Cervantes, A. Naik, Y.N. Kalia, D. Quintanar-Guerrero, and A. Ganem-Quintanar Applications of thermo-reversible pluronic F-127 gels in pharmaceutical formulations J. Pharm. Pharm. Sci. 9 2006 339 358
11. P. Farley Should topical opioid analgesics be regarded as effective and safe when applied to chronic cutaneous lesions? J. Pharm. Pharmacol. 63 2011 747 756
12. P. Flock Pilot study to determine the effectiveness of diamorphine gel to control pressure ulcer pain J. Pain Symptom Manage. 25 2003 547 554
13. S. Heilmann, S. Küchler, and M. Schäfer-Korting Morphine metabolism in human skin microsomes Skin Pharmacol. Physiol. 25 2012 319 322
14. T. Higuchi Rate of release of medicaments from ointment bases containing drugs in suspension J. Pharm. Sci. 50 1961 874 875
15. S. Küchler, N.B. Wolf, S. Heilmann, G. Weindl, J. Helfmann, M.M. Yahya, C. Stein, and M. Schäfer-Korting 3D-Wound healing model: influence of morphine and solid lipid nanoparticles J. Biotechnol. 148 2010 24 30
16. J. Liaw, and Y.-C. Lin Evaluation of poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) (PEO-PPO-PEO) gels as a release vehicle for percutaneous fentanyl J. Control. Release 68 2000 273 282
17. Y. Liu, W.L. Lu, J.C. Wang, X. Zhang, H. Zhang, X.Q. Wang, T.Y. Zhou, and Q. Zhang Controlled delivery of recombinant hirudin based on thermo-sensitive pluronic F127 hydrogel for subcutaneous administration: in vitro and in vivo characterization J. Control. Release 117 2007 387 395
18. S. Lombardi Borgia, P. Schlupp, W. Mehnert, and M. Schäfer-Korting In vitro skin absorption and drug release - a comparison of six commercial prednicarbate preparations for topical use Eur. J. Pharm. Biopharm. 68 2008 380 389
19. D. Missirlis, J.A. Hubbell, and N. Tirelli Thermally-induced glass formation from hydrogel nanoparticles Soft Matter. 2 2006 1067 1075
20. R.M. Nalbandian, R.L. Henry, K.W. Balko, D.V. Adams, and N.R. Neuman Pluronic F-127 gel preparation as an artificial skin in the treatment of third-degree burns in pigs J. Biomed. Mater. Res. 21 1987 1135 1148
21. F. Netzlaff, M. Kaca, U. Bock, E. Haltner-Ukomadu, P. Meiers, C.M. Lehr, and U.F. Schaefer Permeability of the reconstructed human epidermis model Episkin in comparison to various human skin preparations Eur. J. Pharm. Biopharm. 66 2007 127 134
22. F. Netzlaff, C.M. Lehr, P.W. Wertz, and U.F. Schaefer The human epidermis models EpiSkin, SkinEthic and EpiDerm: an evaluation of morphology and their suitability for testing phototoxicity, irritancy, corrosivity, and substance transport Eur. J. Pharm. Biopharm. 60 2005 167 178
23. F. Niedorf, E. Schmidt, and M. Kietzmann The automated, accurate and reproducible determination of steady-state permeation parameters from percutaneous permeation data ATLA 36 2008 201 213
24. M.D. Ribeiro, S.P. Joel, and G. Zeppetella The bioavailability of morphine applied topically to cutaneous ulcers J. Pain Symptom Manage. 27 2004 434 439
25. J.M. Rook, and K.E. McCarson Delay of cutaneous wound closure by morphine via local blockade of peripheral tachykinin release Biochem. Pharmacol. 74 2007 752 757
26. S. Salemi, A. Aeschlimann, N. Reisch, A. Jungel, R.E. Gay, F.L. Heppner, B.A. Michel, S. Gay, and H. Sprott Detection of kappa and delta opioid receptors in skin - outside the nervous system Biochem. Biophys. Res. Commun. 338 2005 1012 1017
27. M. Schäfer-Korting, U. Bock, W. Diembeck, H.J. Dusing, A. Gamer, E. Haltner-Ukomadu, C. Hoffmann, M. Kaca, H. Kamp, S. Kersen, M. Kietzmann, H.C. Korting, H.U. Krachter, C.M. Lehr, M. Liebsch, A. Mehling, C. Müller-Goymann, F. Netzlaff, F. Niedorf, M.K. Rubbelke, U. Schafer, E. Schmidt, S. Schreiber, H. Spielmann, A. Vuia, and M. Weimer The use of reconstructed human epidermis for skin absorption testing: results of the validation study ATLA 36 2008 161 187
28. M. Schäfer-Korting, U. Bock, A. Gamer, A. Haberland, E. Haltner-Ukomadu, M. Kaca, H. Kamp, M. Kietzmann, H.C. Korting, H.U. Krachter, C.M. Lehr, M. Liebsch, A. Mehling, F. Netzlaff, F. Niedorf, M.K. Rubbelke, U. Schäfer, E. Schmidt, S. Schreiber, K.R. Schroder, H. Spielmann, and A. Vuia Reconstructed human epidermis for skin absorption testing: results of the German prevalidation study ATLA 34 2006 283 294
29. I.R. Schmolka Artificial skin. I. Preparation and properties of pluronic F-127 gels for treatment of burns J. Biomed. Mater. Res. 6 1972 571 582
30. C. Stein, H. Machelska, W. Binder, and M. Schäfer Peripheral opioid analgesia Curr. Opin. Pharmacol. 1 2001 62 65
31. A. Takahashi, S. Suzuki, N. Kawasaki, W. Kubo, S. Miyazaki, R. Loebenberg, J. Bachynsky, and D. Attwood Percutaneous absorption of non-steroidal anti-inflammatory drugs from in situ gelling xyloglucan formulations in rats Int. J. Pharm. 246 2002 179 186
32. M. Van Gele, B. Geusens, L. Brochez, R. Speeckaert, and J. Lambert Three-dimensional skin models as tools for transdermal drug delivery: challenges and limitations Expert. Opin. Drug Deliv. 8 2011 705 720
33. N.B. Wolf, S. Küchler, M.R. Radowski, T. Blaschke, K.D. Kramer, G. Weindl, B. Kleuser, R. Haag, and M. Schäfer-Korting Influences of opioids and nanoparticles on in vitro wound healing models Eur. J. Pharm. Biopharm. 73 2009 34 42
34. L. Yu, G. Chang, H. Zhang, and J.D. Ding Temperature-induced spontaneous sol-gel transitions of poly(d,l-lactic acid-co-glycolic acid)-b-poly(ethylene glycol)-b-poly(d,l-lactic acid-co-glycolic acid) triblock copolymers and their end-capped derivatives in water J. Polym. Sci. Part A - Polym. Chem. 45 2007 1122 1133
35. G. Zeppetella, J. Paul, and M.D. Ribeiro Analgesic efficacy of morphine applied topically to painful ulcers J. Pain Symptom Manage. 25 2003 555 558
36. G. Zeppetella, and M.D. Ribeiro Morphine in intrasite gel applied topically to painful ulcers J. Pain Symptom Manage. 29 2005 118 119
37. L. Zhang, D.L. Parsons, C. Navarre, and U.B. Kompella Development and in vitro evaluation of sustained release poloxamer 407 (P407) gel formulations of ceftiofur J. Control. Release 85 2002 73 81